News – Page 430 – Endpoints News

FDA tentatively hints at EUA, with a trial requirement, for Veru's new Covid drug ahead of adcomm

3 years ago

ONO exercises Fate CAR-T option in latest twist to partners' four-year deal

3 years ago

Astellas signals oncology aspirations to healthcare providers in ‘Changemakers’ campaign

3 years ago

Merck continues rare breast cancer campaign focused on challenges for Black women

3 years ago

For $700M+, Viatris nabs two biotechs as eye disease emphasis comes into view

3 years ago

With all hands on deck for lead sickle cell trial, Beam pulls back clinical plans for second base editing therapy

3 years ago

Sensorion nabs rare pediatric designation for gene therapy; Avalo sells off remaining drug rights for $5M

3 years ago

Kura Oncology secures up to $150M in Bristol Myers equity investment, loan from Hercules Capital

3 years ago

As Roche prepares to take a kidney disease drug into PhIII, Ionis fleshes out the data

3 years ago

Updated: Verve's landmark base editing trial for cardio drug runs into FDA hold

3 years ago

GSK reports PhIII flop for BCMA drug — raising questions about its future and upping the stakes on combos

3 years ago

Amgen maps a PhIII journey for its latest great cardio drug hopeful. Can it succeed this time?

3 years ago

Latest news on patient death in n-of-1 CRISPR trial; Good news for RSV; Vaccine R&D revolution; and more

3 years ago

Updated: Flagship sends a vet — post-Rubius implosion — into the breach at Repertoire

3 years ago

Insmed, Alnylam and others make Science's list of top 20 biopharma employers

3 years ago

N-of-1 CRISPR trial ends with a death as nonprofit digs into what happened

3 years ago

Teva reaches $523M agreement with New York in latest opioid-related settlement

3 years ago

Performer Teyana Taylor joins Joe Jonas in helping Merz 'ring the alarm' on frown lines

3 years ago

Novo Nordisk plots commercial relaunch for Wegovy as supplies are expected to return

3 years ago

Santhera lays out options in bid for commercialization funds; Swiss biotech’s Covid work narrows

3 years ago

FDA delays decision for Apellis' eye disease drug after biotech submits updated data

3 years ago

Three years after underwhelming data, Lieping Chen's NextCure drops lead program

3 years ago

Avanir files WARN notice for 100+ layoffs from California as merger with parent Otsuka looms

3 years ago

'Rulebook of microbial ecology': Pianists launch Concerto to treat eczema, protect crops and get rid of BO

3 years ago

First page Previous page 427 428 429430431 432 433 Next page Last page